chronic obstructive pulmonary disease (COPD)

news

Environmentally friendly pressurised Metered Dose Inhaler to be developed

5 December 2019 | By Victoria Rees (European Pharmaceutical Review)

A pharmaceutical company has announced its intention to create a pressurised Metered Dose Inhaler that will reduce the carbon footprint of the drug delivery system.

article

IoT could transform the pharma industry through these steps

27 November 2019 | By James Steiner (Method)

Adopting IoT systems as a pharmaceutical company can provide many opportunities but achieving success can be difficult. James Steiner explains how to effectively integrate IoT solutions into pharma.

news

AstraZeneca receives FDA complete response letter for PT010

2 October 2019 | By Victoria Rees (European Pharmaceutical Review)

The FDA has given a complete response letter to AstraZeneca for its PT010 treatment, regarding its New Drug Application.

news

UK to launch seven data hubs to garner insights for improved healthcare

13 September 2019 | By Victoria Rees (European Pharmaceutical Review)

The seven centres will aid disease research and clinical development, improving access to patient data for studies.

news

Breztri Aerosphere Phase III trial meets primary endpoints

28 August 2019 | By Victoria Rees (European Pharmaceutical Review)

A clinical trial to study a chronic obstructive pulmonary disease treatment has found that the drug is effective and safe.